The burgeoning UK environment surrounding psychedelics is increasingly intricate, demanding careful assessment. While scientific inquiry into compounds like psilocybin and copyright continues to progress, and patient access via private clinics is increasing, the legal framework remains ambiguous. This presents a challenging situation for both patie